PicnicHealth Acquires AllStripes to Elevate Patient-Centric Evidence Generation

PicnicHealth, a pioneer in patient-centered healthcare evidence generation, has announced its acquisition of AllStripes, a platform dedicated to generating evidence about the rare disease community. This strategic consolidation cements PicnicHealth’s position as the leading patient-centric evidence generation partner in the dynamic landscape of life sciences.

Revolutionizing Evidence Generation

Traditionally, gathering comprehensive clinical data and patient-reported outcomes (PROs) has necessitated the establishment of clinical sites—a costly and burdensome process that often leads to delays. PicnicHealth, in collaboration with AllStripes, has reimagined this approach by directly engaging with patients. This novel method offers a more profound understanding of each patient’s health journey while mitigating the challenges associated with traditional site-based studies.

Enhancing Patient Engagement

Noga Leviner, CEO of PicnicHealth, emphasizes the acquisition’s significance in enhancing patient engagement: “Through this acquisition, PicnicHealth will be able to better engage our patient community by incorporating the best of AllStripes’ patient experience into the PicnicHealth platform. Both companies share a common vision of placing patients at the heart of research, unlocking the potential of patient-centered studies, and providing top-notch solutions to support therapeutic development.”

Empowering Biomedical Research

The acquisition reinforces the belief in patient-centric evidence generation’s potential to empower patients and expedite the development of new treatments. Nancy Yu, CEO of AllStripes, affirms, “PicnicHealth will continue both companies’ work to harness the power of patient data to support biomedical research.”

Advancing Solutions

With a focus on making clinical research and registry development more effective and efficient, PicnicHealth will leverage its direct and long-term engagement with both patient communities to expand and enhance solutions for life sciences customers.

Financial Details

While the financial terms of the transaction remain undisclosed, this acquisition follows AllStripes’ successful $50 million Series B funding round in 2021 and PicnicHealth’s $60 million Series C round in 2022.

In summary, PicnicHealth’s acquisition of AllStripes marks a significant milestone in the journey toward patient-centric evidence generation, ultimately benefiting patients, researchers, and the life sciences industry.

TL;DR

• PicnicHealth acquires AllStripes, solidifying its position as a leader in patient-centric evidence generation.
• The acquisition revolutionizes evidence generation by directly engaging with patients, reducing the challenges of traditional site-based studies.
• The focus is on enhancing patient engagement and making clinical research more effective and efficient.
• Both companies share a vision of placing patients at the core of research, supporting therapeutic development.
• Financial terms of the acquisition remain undisclosed.